Increasing Prevalence & Enhanced Diagnosis of Food Allergies
The incidence of cow's milk protein allergy has been steadily escalating, accelerating market growth. As per statistics from the Centers for Disease Control & Prevention (CDC), the number of children with food allergies increased by 50% between 2015 to 2025. This increase is partially due to improved diagnostic techniques and increased awareness among medical professionals & caregivers, resulting in better & earlier diagnoses of CMPA. With the improvement in diagnosis, there comes a corresponding need for more specialized hypoallergenic products and formulas specifically designed for infant and child use with CMPA, fueling market growth.
Growing Recognition of Infant Nutrition and Parental Anxiety
Parents are becoming increasingly aware of their infant's dietary needs & potential allergens. There is a worldwide recognition of the importance of infant nutrition in early childhood & the possible effects of food intolerance. Various public health campaigns & awareness programs undertaken by organizations such as the WHO, which stress the significance of proper infant feeding, are propelling market growth. This awareness is reflected in the active seeking of specialist solutions, such as those based on hydrolyzed and amino acid formulas, upon suspicion or diagnosis of CMPA, thereby increasing the market.
Advancements in Product Development and Formulation
Investigation of new methods of protein hydrolysis, launching advanced probiotic and prebiotic blends, and creating formulas closer to breast milk. The market growth is enhanced by products that contain specific human milk oligosaccharides (HMOs) for promoting gut health in infants with CMPA. Innovations improve the effectiveness and taste of current solutions while also addressing a broader range of allergic sensitivities, with the potential to expand market reach and consumer base.
Emerging Economies and Underserved Regions Expansion
With growing disposable incomes & improved healthcare infrastructure in countries such as Southeast Asia, Latin America, and parts of Africa, there is a greater ability and desire to utilize specialized infant formulas. Government policies aimed at improving the health of mothers & children, along with the increasing birth rate in some of these markets, further stimulating market growth. Building strong distribution channels and providing low-cost, yet effective solutions that cater to local eating habits can go a long way in fueling market growth in these previously underpenetrated geographic regions.
The following Key Market Indicators present a comprehensive overview of the social and economic landscape of the selected region, offering critical insights into market-specific trends and developments. These indicators, combined with data from government statistics, industry associations, and corporate sources, form the analytical foundation of NextGen Intelligence Stats' market models.
| Aspects | Details |
Base Year
|
2024 |
Historic Data
|
2021-2023 |
Forecast Period
|
2025-2035 |
Regions & Countries Covered
|
North America (United States, Canada), Europe (Germany, France, Italy, United Kingdom, Spain, Rest of Europe), Asia Pacific (China, Japan, South Korea, India, Rest of Asia Pacific), Latin America (Brazil, Argentina, Rest of Latin America), Middle East& |
Companies Profile
|
|
Segmentation Level Customization
|
|
Company Level Customization
|
|
Country level Data Customization
|
Segmental volume analysis Pricing Analysis of Product Company Market Share |
•October 2023: Nestlé Health Science launched a new range of hypoallergenic formulas in several European countries, designed to provide enhanced palatability to infants being weaned off extensively hydrolyzed formulas. The product is designed to support the long-term management of CMPA through diet.
•April 2023: Reckitt's subsidiary Mead Johnson & Company, LLC augmented its production capacity of specialty pediatric nutrition products at its plant in Zeeland, Michigan, USA. This addition was to cater to the increasing worldwide demand for hypoallergenic infant formulas.
•March 2023: Novalac launched a new rice-based hypoallergenic formula in select Asian markets, offering a suitable alternative for infants with cow's milk protein allergy who may also have soy allergies or prefer soy-free options. The product emphasizes giving complete nutrition.
The global Allergy market features an innovative and competitive environment dominated by top players who have established themselves through extensive development, diverse product offerings, and global networks. Major players, such as Nestlé Health Science, Mead Johnson & Company, LLC, Abbott, and Nutricia, lead the way with a vast array of specialty formulas, including highly hydrolyzed and amino acid-based ones, which are essential for controlling CMPA. Local and small players, such as Pharmalys, Novalac, Sanulac Nutritionals Australia Pty Ltd, Pristine Organics Pvt Ltd, ViPlus Dairy, and Hero Group, are also driving market growth by targeting niche segments, focusing on organic status or meeting specific regional needs. Competition is also influenced by strategic partnerships, acquisitions, and ongoing innovations to create more tolerable and efficient solutions for cow milk protein allergy in infants and children.
• Nestle Health Science
• Nutricia (Danone Group company)
• Mead Johnson & Company, LLC
• Abbott
• Pharmalys
• Novalac
• Sanulac Nutritionals Australia Pty Ltd
• Pristine Organics Pvt Ltd
• ViPlus Dairy
• Hero Group
• Others
The cow milk protein allergy market was worth USD 799.44 million in 2024 and is anticipated to reach USD 1863.36 million during the forecast period of 3035, growing at a CAGR of 7.6%.
The Cow Milk Protein Allergy market is poised to grow at a CAGR of 7.6% from 2025 to 2035.
Increasing Prevalence & Enhanced Diagnosis of Food Allergies, Growing Recognition of Infant Nutrition and Parental Anxiety, Advancements in Product Development and Formulation, Emerging Economies and Underserved Regions Expansion
Asia Pacific held largest share accounting for approximately 7.8% of the revenues in 2024
Nestle Health Science, Nutricia (Danone Group company), Mead Johnson & Company, LLC, Abbott, Pharmalys
North America acquired 35.8% share of the market due to the greater prevalence of food allergies in the region.
1.1. Introduction
1.2. Report Description & Objective
1.3. Years Considered For Study
1.4. Assumption And Limitation
2.1. Data Collection
2.2. Primary Research & Secondary Research
2.3. Bottom-Up Approach & Top-Down Approach
2.4. Market Analysis & Size Estimation
2.5. Quality Check & Final Review
3.1. Report Scope
3.2. Executive Summary
4.1. Top Trends To Watch
4.2. Top Strategies Followed By Key Players
4.3. Top Investment Pockets
4.4. Strategic Recommendations
5.1. Market Definition
5.2. Market Drivers
5.3. Market Restraints & Challenges
5.4. Market Opportunities
6.1. Porter’s Five Forces’ Analysis
6.2. Value Chain Analysis / Supply Chain Analysis
6.3. PESTLE Analysis
6.4. Regulatory Landscape
6.5. Pricing Analysis
6.6. Go to Market Strategy
7.1. Global Cow Milk Protein Allergy Market, By Product Type
7.2. Global Cow Milk Protein Allergy Market Attractiveness, By Product Type
7.2.1. Extensively Hydrolyzed Formulas (eHFs)
7.2.2. Amino Acid-Based Formulas (AAFs)
7.2.3. Soy-Based Formulas
7.2.4. Rice-Based Formulas
7.2.5. Other Hypoallergenic Products
8.1. Global Cow Milk Protein Allergy Market, By End Users
8.2. Global Cow Milk Protein Allergy Market Attractiveness, By End Users
8.2.1. Infants (0-12 months)
8.2.2. Toddlers (1-3 years)
8.2.3. Children (Above 3 years)
9.1. Global Cow Milk Protein Allergy Market, By Distribution Channel
9.2. Global Cow Milk Protein Allergy Market Attractiveness, By Distribution Channel
9.2.1. Hospital Pharmacies
9.2.2. Retail Pharmacies
9.2.3. Online Pharmacies
10.1. Global Cow Milk Protein Allergy Market, By Geography
10.2. Global Cow Milk Protein Allergy Market Attractiveness, By Geography
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Middle East & Africa
10.2.5. Latin America
11.1. North America Market Overview, By Countries
11.2. Market Overview, By Type
11.3. Market Overview, By Application
11.3.1. United States
11.3.2. Canada
12.1. Europe Market Overview, By Countries
12.2. Market Overview, By Type
12.3. Market Overview, By Application
12.3.1. Germany
12.3.2. France
12.3.3. UK
12.3.4. Italy
12.3.5. Spain
12.3.6. Rest of Europe
13.1. Asia Pacific Market Overview, By Countries
13.2. Market Overview, By Type
13.3. Market Overview, By Application
13.3.1. India
13.3.2. China
13.3.3. Japan
13.3.4. Latin Korea
13.3.5. Rest of Asia Pacific
14.1. Middle East & Africa Market Overview, By Countries
14.2. Market Overview, By Type
14.3. Market Overview, By Application
14.3.1. GCC
14.3.2. Latin Africa
14.3.3. Rest of Middle East & Africa
15.1. Latin America Market Overview, By Countries
15.2. Market Overview, By Type
15.3. Market Overview, By Application
15.3.1. Brazil
15.3.2. Argentina
15.3.3. Rest of Latin America
16.1. Key Developments
16.1.1. Partnerships, Collaborations, Agreements
16.1.2. Mergers & Acquisitions
16.1.3. New Product Developments
16.1.4. Other Developments
16.2. Company Share Analysis
16.3. Company Profiles
16.3.1. Nestl Health Science
16.3.1.1. Company Overview
16.3.1.2. Product Overview
16.3.1.3. Financial Insights
16.3.1.4. Recent Developments
16.3.1.5. SWOT Analysis
16.3.2. Nutricia (Danone Group company)
16.3.3. Mead Johnson & Company, LLC
16.3.4. Abbott
16.3.5. Pharmalys
16.3.6. Novalac
16.3.7. Sanulac Nutritionals Australia Pty Ltd
16.3.8. Pristine Organics Pvt Ltd
16.3.9. ViPlus Dairy
16.3.10. Hero Group
Data Collection
Primary Research & Secondary Research
Bottom-Up Approach & Top-Down Approach
Market Analysis & Size Estimation
Quality Check & Final Review
By Product Type
• Extensively Hydrolyzed Formulas (eHFs)
• Amino Acid-Based Formulas (AAFs)
• Soy-Based Formulas
• Rice-Based Formulas
• Other Hypoallergenic Products
By End Users
• Infants (0-12 months)
• Toddlers (1-3 years)
• Children (Above 3 years)
By Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Supermarkets/Hypermarkets
© NextGen Intelligence Stats and Consulting LLP All rights reserved.
